nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ABCB1—peripheral nervous system neoplasm	0.412	1	CbGaD
Prednisone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0456	0.167	CbGbCtD
Prednisone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0456	0.167	CbGbCtD
Prednisone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0316	0.116	CbGbCtD
Prednisone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0273	0.1	CbGbCtD
Prednisone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0254	0.0931	CbGbCtD
Prednisone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0195	0.0714	CbGbCtD
Prednisone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0181	0.0665	CbGbCtD
Prednisone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0178	0.0654	CbGbCtD
Prednisone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0446	CbGbCtD
Prednisone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0117	0.0428	CbGbCtD
Prednisone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0107	0.0392	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00728	0.0267	CbGbCtD
Prednisone—HSD11B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00436	0.403	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000447	0.0413	CbGpPWpGaD
Prednisone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00042	0.392	CrCbGaD
Prednisone—HSD11B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000295	0.0272	CbGpPWpGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.00028	0.0258	CbGpPWpGaD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000264	0.0244	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.000251	0.0232	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000241	0.0223	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000199	0.0184	CbGpPWpGaD
Prednisone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000195	0.182	CrCbGaD
Prednisone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000181	0.0168	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000166	0.0153	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000162	0.015	CbGpPWpGaD
Prednisone—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000154	0.0142	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GNS—peripheral nervous system neoplasm	0.000144	0.0133	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—NME1—peripheral nervous system neoplasm	0.000138	0.0127	CbGpPWpGaD
Prednisone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000138	0.128	CrCbGaD
Prednisone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000135	0.126	CrCbGaD
Prednisone—HSD11B1—Metabolism—COX2—peripheral nervous system neoplasm	0.000133	0.0123	CbGpPWpGaD
Prednisone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000399	CcSEcCtD
Prednisone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000399	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.000121	0.0111	CbGpPWpGaD
Prednisone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00012	0.000397	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000397	CcSEcCtD
Prednisone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00012	0.000396	CcSEcCtD
Prednisone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00012	0.000396	CcSEcCtD
Prednisone—Rash—Topotecan—peripheral nervous system neoplasm	0.00012	0.000396	CcSEcCtD
Prednisone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00012	0.000396	CcSEcCtD
Prednisone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00012	0.000396	CcSEcCtD
Prednisone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000395	CcSEcCtD
Prednisone—Headache—Topotecan—peripheral nervous system neoplasm	0.000119	0.000394	CcSEcCtD
Prednisone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000119	0.000393	CcSEcCtD
Prednisone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000119	0.000392	CcSEcCtD
Prednisone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000119	0.000391	CcSEcCtD
Prednisone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000391	CcSEcCtD
Prednisone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000118	0.000391	CcSEcCtD
Prednisone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000118	0.000391	CcSEcCtD
Prednisone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000118	0.00039	CcSEcCtD
Prednisone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000389	CcSEcCtD
Prednisone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000118	0.000389	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000389	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000389	CcSEcCtD
Prednisone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000389	CcSEcCtD
Prednisone—Rash—Melphalan—peripheral nervous system neoplasm	0.000118	0.000388	CcSEcCtD
Prednisone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000118	0.000388	CcSEcCtD
Prednisone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000386	CcSEcCtD
Prednisone—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000386	CcSEcCtD
Prednisone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000384	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000383	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000383	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000116	0.000382	CcSEcCtD
Prednisone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000115	0.00038	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000376	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.000376	CcSEcCtD
Prednisone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000375	CcSEcCtD
Prednisone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000374	CcSEcCtD
Prednisone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000374	CcSEcCtD
Prednisone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000113	0.000373	CcSEcCtD
Prednisone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000113	0.000372	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000371	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000371	CcSEcCtD
Prednisone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.00037	CcSEcCtD
Prednisone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000112	0.00037	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00037	CcSEcCtD
Prednisone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000112	0.000369	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000369	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000367	CcSEcCtD
Prednisone—Infection—Etoposide—peripheral nervous system neoplasm	0.000111	0.000366	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000366	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000111	0.000366	CcSEcCtD
Prednisone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000111	0.000366	CcSEcCtD
Prednisone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000362	CcSEcCtD
Prednisone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000109	0.00036	CcSEcCtD
Prednisone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000109	0.00036	CcSEcCtD
Prednisone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000109	0.00036	CcSEcCtD
Prednisone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000109	0.000358	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000108	0.00999	CbGpPWpGaD
Prednisone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000357	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000108	0.000357	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000357	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000354	CcSEcCtD
Prednisone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000107	0.000352	CcSEcCtD
Prednisone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00035	CcSEcCtD
Prednisone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000106	0.000349	CcSEcCtD
Prednisone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000106	0.000348	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000105	0.0983	CrCbGaD
Prednisone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000343	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000343	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00034	CcSEcCtD
Prednisone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000339	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000339	CcSEcCtD
Prednisone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000102	0.000336	CcSEcCtD
Prednisone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000334	CcSEcCtD
Prednisone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000332	CcSEcCtD
Prednisone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.0001	0.000331	CcSEcCtD
Prednisone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000331	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00033	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000329	CcSEcCtD
Prednisone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	9.96e-05	0.00919	CbGpPWpGaD
Prednisone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000328	CcSEcCtD
Prednisone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	9.93e-05	0.00917	CbGpPWpGaD
Prednisone—Asthenia—Vincristine—peripheral nervous system neoplasm	9.9e-05	0.000327	CcSEcCtD
Prednisone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.82e-05	0.000324	CcSEcCtD
Prednisone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.8e-05	0.000323	CcSEcCtD
Prednisone—Rash—Dactinomycin—peripheral nervous system neoplasm	9.74e-05	0.000321	CcSEcCtD
Prednisone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.72e-05	0.000321	CcSEcCtD
Prednisone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.65e-05	0.000318	CcSEcCtD
Prednisone—Fatigue—Etoposide—peripheral nervous system neoplasm	9.64e-05	0.000318	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000318	CcSEcCtD
Prednisone—Constipation—Etoposide—peripheral nervous system neoplasm	9.56e-05	0.000315	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000315	CcSEcCtD
Prednisone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.47e-05	0.000313	CcSEcCtD
Prednisone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.44e-05	0.000312	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000306	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000304	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.21e-05	0.000304	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.000304	CcSEcCtD
Prednisone—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.18e-05	0.000303	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.14e-05	0.000302	CcSEcCtD
Prednisone—Dizziness—Vincristine—peripheral nervous system neoplasm	9.13e-05	0.000301	CcSEcCtD
Prednisone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.11e-05	0.0003	CcSEcCtD
Prednisone—Rash—Alitretinoin—peripheral nervous system neoplasm	9.03e-05	0.000298	CcSEcCtD
Prednisone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.02e-05	0.000298	CcSEcCtD
Prednisone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.99e-05	0.000297	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000296	CcSEcCtD
Prednisone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.97e-05	0.000296	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000294	CcSEcCtD
Prednisone—Urticaria—Etoposide—peripheral nervous system neoplasm	8.88e-05	0.000293	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000293	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.84e-05	0.000292	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.84e-05	0.000292	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.000291	CcSEcCtD
Prednisone—Vomiting—Vincristine—peripheral nervous system neoplasm	8.78e-05	0.00029	CcSEcCtD
Prednisone—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000289	CcSEcCtD
Prednisone—HSD11B1—Metabolism—ENO2—peripheral nervous system neoplasm	8.72e-05	0.00805	CbGpPWpGaD
Prednisone—Rash—Vincristine—peripheral nervous system neoplasm	8.7e-05	0.000287	CcSEcCtD
Prednisone—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.7e-05	0.000287	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.000286	CcSEcCtD
Prednisone—Headache—Vincristine—peripheral nervous system neoplasm	8.65e-05	0.000285	CcSEcCtD
Prednisone—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.51e-05	0.000281	CcSEcCtD
Prednisone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.35e-05	0.000276	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000274	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000272	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.24e-05	0.000272	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000271	CcSEcCtD
Prednisone—Nausea—Vincristine—peripheral nervous system neoplasm	8.2e-05	0.00027	CcSEcCtD
Prednisone—Flushing—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.00027	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000269	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.14e-05	0.00752	CbGpPWpGaD
Prednisone—Asthenia—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000265	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000265	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000264	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000263	CcSEcCtD
Prednisone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.91e-05	0.000261	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.00026	CcSEcCtD
Prednisone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	7.85e-05	0.0732	CrCbGaD
Prednisone—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000257	CcSEcCtD
Prednisone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.76e-05	0.000256	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000255	CcSEcCtD
Prednisone—Rash—Cisplatin—peripheral nervous system neoplasm	7.7e-05	0.000254	CcSEcCtD
Prednisone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.69e-05	0.000254	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000253	CcSEcCtD
Prednisone—Erythema—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000253	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.65e-05	0.000252	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000252	CcSEcCtD
Prednisone—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.00025	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000244	CcSEcCtD
Prednisone—Dizziness—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000244	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000243	CcSEcCtD
Prednisone—HSD11B1—Metabolism—BCHE—peripheral nervous system neoplasm	7.37e-05	0.00681	CbGpPWpGaD
Prednisone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000241	CcSEcCtD
Prednisone—Nausea—Cisplatin—peripheral nervous system neoplasm	7.25e-05	0.000239	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000239	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.000238	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000236	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000235	CcSEcCtD
Prednisone—Vomiting—Etoposide—peripheral nervous system neoplasm	7.11e-05	0.000235	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000234	CcSEcCtD
Prednisone—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000234	CcSEcCtD
Prednisone—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000234	CcSEcCtD
Prednisone—Agitation—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000233	CcSEcCtD
Prednisone—Rash—Etoposide—peripheral nervous system neoplasm	7.05e-05	0.000233	CcSEcCtD
Prednisone—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.04e-05	0.000232	CcSEcCtD
Prednisone—HSD11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.03e-05	0.00649	CbGpPWpGaD
Prednisone—Headache—Etoposide—peripheral nervous system neoplasm	7.01e-05	0.000231	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	6.94e-05	0.00641	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—TH—peripheral nervous system neoplasm	6.93e-05	0.0064	CbGpPWpGaD
Prednisone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000228	CcSEcCtD
Prednisone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000228	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	6.9e-05	0.00637	CbGpPWpGaD
Prednisone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000227	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000223	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000221	CcSEcCtD
Prednisone—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.00022	CcSEcCtD
Prednisone—Nausea—Etoposide—peripheral nervous system neoplasm	6.64e-05	0.000219	CcSEcCtD
Prednisone—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000219	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000218	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000217	CcSEcCtD
Prednisone—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000216	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000216	CcSEcCtD
Prednisone—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000215	CcSEcCtD
Prednisone—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000215	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000214	CcSEcCtD
Prednisone—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000213	CcSEcCtD
Prednisone—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000211	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000211	CcSEcCtD
Prednisone—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.00021	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	6.36e-05	0.00587	CbGpPWpGaD
Prednisone—Oedema—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000207	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000207	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000206	CcSEcCtD
Prednisone—Infection—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000205	CcSEcCtD
Prednisone—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	6.21e-05	0.00573	CbGpPWpGaD
Prednisone—Shock—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000203	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000203	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000203	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000202	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000202	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000201	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.0002	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.0002	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.0002	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000199	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000198	CcSEcCtD
Prednisone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.99e-05	0.00553	CbGpPWpGaD
Prednisone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000197	CcSEcCtD
Prednisone—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000197	CcSEcCtD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	5.92e-05	0.00546	CbGpPWpGaD
Prednisone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000191	CcSEcCtD
Prednisone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000191	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.79e-05	0.00534	CbGpPWpGaD
Prednisone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.00019	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000188	CcSEcCtD
Prednisone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000188	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.7e-05	0.00527	CbGpPWpGaD
Prednisone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000188	CcSEcCtD
Prednisone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000187	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000187	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	5.66e-05	0.00523	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GNAS—peripheral nervous system neoplasm	5.66e-05	0.00522	CbGpPWpGaD
Prednisone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000186	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000186	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000185	CcSEcCtD
Prednisone—HSD11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.55e-05	0.00513	CbGpPWpGaD
Prednisone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000182	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000182	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.00018	CcSEcCtD
Prednisone—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000178	CcSEcCtD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	5.38e-05	0.00497	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.37e-05	0.00496	CbGpPWpGaD
Prednisone—Constipation—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000177	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000174	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000173	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000172	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	5.18e-05	0.00478	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	5.17e-05	0.00478	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.17e-05	0.00477	CbGpPWpGaD
Prednisone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.00017	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000169	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000168	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000166	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000165	CcSEcCtD
Prednisone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000164	CcSEcCtD
Prednisone—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000164	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000163	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000163	CcSEcCtD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	4.93e-05	0.00455	CbGpPWpGaD
Prednisone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000158	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000156	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000152	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000152	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000151	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000151	CcSEcCtD
Prednisone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000148	CcSEcCtD
Prednisone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000146	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000141	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000141	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000137	CcSEcCtD
Prednisone—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000137	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000135	CcSEcCtD
Prednisone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000131	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.98e-05	0.00367	CbGpPWpGaD
Prednisone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000131	CcSEcCtD
Prednisone—Rash—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.00013	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.00013	CcSEcCtD
Prednisone—Headache—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.00013	CcSEcCtD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.86e-05	0.00356	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	3.84e-05	0.00354	CbGpPWpGaD
Prednisone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000127	CcSEcCtD
Prednisone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000123	CcSEcCtD
Prednisone—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	3.72e-05	0.00343	CbGpPWpGaD
Prednisone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000122	CcSEcCtD
Prednisone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000121	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000121	CcSEcCtD
Prednisone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.00012	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.63e-05	0.00335	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.57e-05	0.0033	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000114	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	3.41e-05	0.00315	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	3.15e-05	0.00291	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.01e-05	0.00278	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	2.97e-05	0.00274	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.84e-05	0.00262	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	2.78e-05	0.00256	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.75e-05	0.00254	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.74e-05	0.00253	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.73e-05	0.00252	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.63e-05	0.00243	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.62e-05	0.00242	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.62e-05	0.00242	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.59e-05	0.00239	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.58e-05	0.00239	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.52e-05	0.00233	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.51e-05	0.00232	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.42e-05	0.00223	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.4e-05	0.00221	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	2.37e-05	0.00219	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.37e-05	0.00218	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.36e-05	0.00218	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.36e-05	0.00217	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	2.34e-05	0.00216	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.3e-05	0.00212	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.29e-05	0.00212	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.21e-05	0.00204	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.2e-05	0.00203	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.00199	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.02e-05	0.00187	CbGpPWpGaD
Prednisone—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.77e-05	0.00164	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.59e-05	0.00147	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.00147	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.55e-05	0.00143	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.53e-05	0.00141	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.53e-05	0.00141	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.5e-05	0.00138	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.47e-05	0.00136	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.42e-05	0.00131	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.42e-05	0.00131	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.34e-05	0.00124	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.00123	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.32e-05	0.00122	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.3e-05	0.0012	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.28e-05	0.00118	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.00118	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.26e-05	0.00117	CbGpPWpGaD
Prednisone—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.24e-05	0.00115	CbGpPWpGaD
Prednisone—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.23e-05	0.00113	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.18e-05	0.00109	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.18e-05	0.00109	CbGpPWpGaD
Prednisone—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.18e-05	0.00109	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.17e-05	0.00108	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.15e-05	0.00106	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.00104	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.1e-05	0.00102	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.08e-05	0.000994	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000992	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.00098	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.05e-05	0.000974	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.04e-05	0.000956	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000951	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.000933	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.57e-06	0.000883	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.42e-06	0.000869	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.23e-06	0.000852	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.63e-06	0.000797	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.54e-06	0.000788	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	7.76e-06	0.000717	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.58e-06	0.0007	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	6.97e-06	0.000643	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.92e-06	0.000638	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.8e-06	0.000628	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.63e-06	0.000612	CbGpPWpGaD
Prednisone—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	6.56e-06	0.000605	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.5e-06	0.0006	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.4e-06	0.000591	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.38e-06	0.000589	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.26e-06	0.000578	CbGpPWpGaD
Prednisone—ALB—Metabolism—TH—peripheral nervous system neoplasm	6.17e-06	0.000569	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	5.89e-06	0.000544	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.75e-06	0.000531	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.62e-06	0.000519	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.54e-06	0.000511	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.48e-06	0.000506	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.4e-06	0.000499	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	5.19e-06	0.000479	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	5.03e-06	0.000465	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	4.94e-06	0.000456	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.52e-06	0.000417	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.43e-06	0.000409	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.41e-06	0.000407	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.19e-06	0.000387	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	4.11e-06	0.000379	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3.97e-06	0.000366	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	3.8e-06	0.00035	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.54e-06	0.000327	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.38e-06	0.000312	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.35e-06	0.000309	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.33e-06	0.000307	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.85e-06	0.000263	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.78e-06	0.000257	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.72e-06	0.000251	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.67e-06	0.000246	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.36e-06	0.000125	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.22e-06	0.000113	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-06	0.00011	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.33e-07	6.77e-05	CbGpPWpGaD
